Global InsurTech funding surged to $2.44 billion in the second quarter of 2026, marking the highest quarterly total since Q2 2022, according to Gallagher Re’s latest Global InsurTech Report. The surge reflects a dramatic shift in how insurance technology investors are allocating capital, with artificial intelligence-focused companies capturing nearly all of the available funding.
AI-focused companies attracted 99.1% of all Q2 2026 funding, raising $2.42 billion across 95 deals. Every funding round larger than $5 million went to AI-backed firms, underscoring the market’s singular focus on technology that can automate and enhance insurance operations.
Mega-round funding drove much of the quarter’s growth. Large deals above $5 million accounted for $1.67 billion, or 68.4% of total funding, according to Gallagher Re. This concentration of capital into larger transactions marks a departure from earlier patterns in the insurance technology sector, where funding had been more distributed across deal sizes.
The momentum followed a strong Q1 2026, when InsurTech funding reached $1.63 billion. However, the composition of funding shifted dramatically between the quarters. AI’s share of total funding rose from 95.2% in Q1 to 99.1% in Q2, indicating accelerating market concentration.
Early-stage funding, by contrast, experienced sharp pressure. Seed and early-stage investments fell 51.8% quarter-over-quarter, declining from $548 million in Q1 to $264.19 million in Q2, even as the number of early-stage deals reached 54 transactions. This divergence suggests investors are betting on mature, AI-ready companies rather than funding nascent startups.
The reinsurance industry also scaled back its venture participation. (Re)insurance companies backed 27 InsurTech investments in Q2, down from 32 in Q1 2026, with 51.9% of those investments targeting early-stage firms. This retreat reflects broader market dynamics in which traditional insurance players are becoming more selective about funding InsurTech ventures.
Gallagher Re’s report notes that the funding surge masks a possible narrowing of the industry’s innovation pipeline, particularly for incumbent insurers seeking to invest in emerging technologies. The concentration of capital into mega-rounds and AI-focused firms may limit opportunities for alternative approaches and early-stage innovation that fall outside the dominant AI narrative.
Sources
- Gallagher Re — Global InsurTech Report for Q2 2026, published August 6, 2026; confirmed Q2 2026 funding of $2.44 billion, the highest since Q2 2022, with 99.1% flowing to AI-focused companies and mega-round funding comprising 68.4% of total capital.
- Financial Technology Partners (FT Partners) — Quarterly InsurTech Insights; confirmed Q1 2026 InsurTech financing volume of more than $1.6 billion, representing a 35% year-over-year increase.
- Insurance Business Magazine — Analysis of Gallagher Re’s Q2 2026 findings; reported AI funding share rose from 95.2% in Q1 2026 to 99.1% in Q2 2026, and early-stage funding declined 51.8% quarter-over-quarter.
- Reinsurance News — Coverage of Gallagher Re report; confirmed Q2 2026 as the highest quarterly total since Q2 2022 and noted AI-focused companies attracted 99.1% of all funding.
